Rudolf Tomek, Eduard Vrdoljak, Damir Vrbanec, Damir Nemet, Visnja Matković, Stjepko Plestina, Damir Gugić, Renata Dobrila Dintinjana, Ante Bolanca, Miro Samarzija, Marija Petković
Approximately 70-80% of all cancer patients receiving chemotherapy experience nausea and/or vomiting. Nausea and vomiting are important side effects of cancer treatment, which can significantly affect a patient's quality of life, leading to poor compliance with further chemotherapy treatment. The main principle of emesis control is prevention. Currently available antiemetic agents corticosteroids, 5-hydroxytriptamine receptor antagonists, and neurokinin-1 antagonists, are used alone or in combination. Antiemetic regimen should be chosen based on the emetogenic potential of the chemotherapy regimen, previous experience with antiemetics, and patient-specific risk factors...
March 2009: Lijec̆nic̆ki Vjesnik